Investment
Features
FeesSafety
Academy
More
Pluang+

Labcorp upgraded to Buy on strong Q2 results and resilient diagnostics demand despite Medicare cuts.

Analyst Insights
22 Sep 2026
Seeking Alpha
View Source
Bullish
Labcorp upgraded to Buy on strong Q2 results and resilient diagnostics demand despite Medicare cuts.

Labcorp Holdings Inc. received a Buy upgrade due to its strong Q2 performance and steady demand for diagnostic services, even with impending Medicare rate reductions. The company has outperformed the S&P 500 and healthcare peers year-to-date, supported by solid technical indicators and positive operating margins. Its growth is further supported by new test launches and a diversified biopharma segment, which help mitigate regulatory risks. Labcorp's stock valuation is considered modest, with forecasts predicting total returns exceeding 9.9% by 2027, making it an attractive option for long-term growth and dividend income investors.

Labcorp Holdings Inc. is noted here with a market context snapshot from Pluang's health sector data. For readers following health stocks, as of Sep 23, 2026 03:31 WIB, 64 of 101 priced US health-sector stocks on Pluang rose while 37 fell. Among notable movers were BioNano Genomics Inc (BNGO) with a 1-day change of +7.51% and a typical hold time of 49 days, GeneDx Holdings Corp (WGS) down 7.49% with a 19-day hold time, and Sana Biotechnology Inc (SANA) up 6.77% with a 22-day hold time and 100% buy order activity.

More News

WM Vice President sells 1,365 shares worth $300,000 in insider transaction

WM Vice President sells 1,365 shares worth $300,000 in insider transaction

A Vice President at WM sold 1,365 shares valued at $300,000. Insider sales like this can indicate the executive's personal financial decisions but do not necessarily reflect the company's outlook. Investors should watch for any further insider activi...

Market News
Bearish
1 hour ago
BMO Capital rates Tenet Healthcare 'Market Perform' with 24% EPS growth forecast

BMO Capital rates Tenet Healthcare 'Market Perform' with 24% EPS growth forecast

BMO Capital initiated coverage on Tenet Healthcare with a 'Market Perform' rating, indicating the stock is expected to perform in line with the broader market. The company is forecasted to report a 24.05% increase in Earnings Per Share (EPS) to $4.59...

Analyst Insights
Neutral
3 hours ago
Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

The market experienced a downturn with significant losses among key stocks. New Fortress Energy dropped 24.7% amid ongoing volatility in energy sectors, while Xanadu Quantum Technologies fell 21.7% reflecting sensitivity in quantum stocks to commerci...

Market News
Bearish
3 hours ago
Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Jaguar Health (JAGX) surged over 1,150% after the FDA granted fee waivers for its drugs Mytesi and Canalevia-CA1, signaling regulatory support. Greenland Mines (GRML) rose nearly 50% amid growing investor interest linked to U.S.-Greenland security de...

Market News
Bullish
3 hours ago
Europe launches first Zcash ETP, enabling crypto exposure via traditional securities accounts.

Europe launches first Zcash ETP, enabling crypto exposure via traditional securities accounts.

On September 22, 2026, 21Shares AG introduced Europe's first exchange-traded product (ETP) tracking Zcash (ZEC) on Euronext Amsterdam and Paris. This allows investors to gain Zcash exposure through regular securities accounts without needing crypto w...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App